Low-Sugar High-Fat Diet for Cystic Fibrosis
(FEED-CF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a diet low in added sugars but high in fat can reduce diabetes risk in people with cystic fibrosis (CF). Participants will follow either a typical high-sugar, high-fat CF diet (the "High-added sugar, high-fat CF diet") or a low-sugar, high-fat diet (the "Low-added sugar, high-fat diet") for eight weeks. Researchers aim to determine if reducing sugar intake helps prevent diabetes and decreases fat around the organs. Individuals with CF who consume more than 16 teaspoons of added sugar daily and manage their condition without certain complications may be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve dietary recommendations for CF patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does require that your medical regimen, including medications, has not changed for at least 21 days before the study. This suggests that you should not make changes to your medications right before or during the trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that a diet low in added sugar and high in fat is safe for people with cystic fibrosis (CF). An earlier study found that adults with CF tolerated this diet well, with no major safety issues or serious side effects. This finding provides a solid basis for further research.
The aim is to determine if reducing sugar can help address issues like glucose intolerance and body fat in people with CF. Participants on this diet avoided common problems linked to high sugar intake, suggesting it might be a good option for those concerned about the risk of diabetes.12345Why are researchers excited about this trial?
Researchers are excited about the new dietary approaches for cystic fibrosis (CF) because they explore how altering sugar intake can impact health. Unlike the typical CF diet, which is high in added sugars and fats, the low-added sugar, high-fat diet aims to manage energy intake while potentially reducing the negative effects associated with high sugar consumption. This unique approach could offer insights into how diet modification might improve the quality of life and health outcomes for people with CF. By delivering all meals directly to participants' homes, the study ensures precise control over dietary intake, which is crucial for understanding the true effects of these dietary changes.
What evidence suggests that this trial's diets could be effective for cystic fibrosis-related diabetes?
Research has shown that reducing added sugar in the diet may help people with cystic fibrosis (CF) manage blood sugar issues. One study found that consuming less added sugar improved diabetes risk markers and reduced belly fat. These changes are crucial for people with CF, who are more prone to developing CF-related diabetes (CFRD). Another study indicated that the typical high-fat, high-sugar diet for CF could harm heart health as individuals with CF age. This trial will compare a low-added sugar, high-fat diet with a typical high-added sugar, high-fat CF diet. Reducing added sugar while maintaining a high-fat diet might improve health for those with CF.12367
Who Is on the Research Team?
Jessica A Alvarez, PhD, RD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
Adults over 18 with confirmed cystic fibrosis, who consume more than 16 teaspoons of added sugar daily and have exocrine pancreatic insufficiency can join. Those with CFRD, recent CFTR modulator use, organ transplant waiting list status, life expectancy under a year, uncontrolled conditions or dietary restrictions that conflict with the study's menu are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline visit for an insulin secretion test and MRI testing to measure visceral fat
Treatment
Participants receive either a low-added sugar, high-fat diet or a typical CF diet for 8 weeks
Midpoint Check-in
4-week visit for an oral glucose tolerance test and in-person check-in
Follow-up
8-week visit for another GPA and MRI to assess changes in risk markers for diabetes and visceral fat
What Are the Treatments Tested in This Trial?
Interventions
- High-added sugar, high-fat CF diet
- Low-added sugar, high-fat diet
Trial Overview
The FEED-CF trial is testing how diet affects diabetes risk in cystic fibrosis patients by comparing two diets: one low in added sugars but high in fats versus the standard high-sugar, high-fat CF diet. Participants will be randomly assigned to one of these diets for 8 weeks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Patients will receive a low-added sugar, high-fat diet for 8 weeks. Study menus will be designed by registered dietitians using the Nutrient Database System for Research (NDSR) software program with a 2-wk rotation.Total kcal provided will be individually tailored to maintain body weight and adjusted throughout as needed. All foods (including snacks and drinks) for 8 wks will be delivered to participants' homes. Menus will be designed so that food will be delivered to subjects' homes every 3-4 days. It will be expected that participants consume only the foods provided by the study.
Patients will receive a high-added sugar, high-fat CF diet for 8 weeks. Study menus will be designed by registered dietitians using the Nutrient Database System for Research (NDSR) software program with a 2-wk rotation. Total kcal provided will be individually tailored to maintain body weight and adjusted throughout as needed. All foods (including snacks and drinks) for 8 wks will be delivered to participants' homes. Menus will be designed so that food will be delivered to subjects' homes every 3-4 days. It will be expected that participants consume only the foods provided by the study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Published Research Related to This Trial
Citations
Low-added sugar dietary intervention study to mitigate ...
Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis
2.
clinicaltrials.gov
clinicaltrials.gov/study/NCT05766774?term=NIDDK%20endocrine%20and%20diabetes&spons=NIDDK&aggFilters=status:not%20rec%20act&viewType=Table&rank=5NCT05766774 | FEED-Cystic Fibrosis (FEED-CF)
In this study, the investigators will test if a low-added sugar diet improves risk markers for diabetes and decreases visceral fat over 8 weeks. The study will ...
Low-Sugar High-Fat Diet for Cystic Fibrosis (FEED-CF Trial)
In a study of 169 participants on a hypocaloric, low-fat diet, significant reductions in high-fat and high-added-sugar food groups were observed over 6 months, ...
Dietary Intake & Faecal Microbiota in Cystic Fibrosis Children
The results reveal that a “high-fat, high-energy” diet does not satisfy dietary fibre intake from healthy food sources in children with CF.
Nutritional considerations for a new era: CF foundation paper
The traditional high fat, high calorie CF diet may have negative nutritional and cardiovascular consequences as pwCF age.
What do people with cystic fibrosis eat? Diet quality, ...
The overall diet quality of adults with cystic fibrosis is poor. All studies were over cystic fibrosis recommended total energy intake from fat.
Safety and tolerability of a low glycemic load dietary ...
Discussion: A LGL dietary intervention was safe and well tolerated in adults with CF and AGT. These results lay the groundwork for future trials ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.